Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
OTP, CD44, and Ki-67: A prognostic marker panel for relapse free survival in patients with surgically resected pulmonary carcinoid.
Moonen L, Derks JL, den Bakker MA, Hillen LM, Jan van Suylen R, von der Thüsen JH, Lap LMV, Marijnissen BJCA, Damhuis RA, Smits KM, van den Broek EC, Buikhuisen WA; PALGA group; Dingemans AC, Speel EJM. Moonen L, et al. Among authors: von der thusen jh. Mod Pathol. 2024 Dec 2:100677. doi: 10.1016/j.modpat.2024.100677. Online ahead of print. Mod Pathol. 2024. PMID: 39631518 Free article.
Development and verification of new monoclonal orthopedia homeobox (OTP) specific antibodies for pulmonary carcinoid diagnostics.
Moonen L, Derks JL, Lap LMV, Marijnissen BJCA, Hillen LM, den Bakker MA, von der Thüsen JH, van Suylen RJ, Timens W, Bintanel M, Kuteeva E, Dingemans AC, Speel EM. Moonen L, et al. Among authors: von der thusen jh. Transl Lung Cancer Res. 2022 Nov;11(11):2181-2191. doi: 10.21037/tlcr-22-418. Transl Lung Cancer Res. 2022. PMID: 36519022 Free PMC article.
Efficacy and Tolerability of Osimertinib and Sotorasib Combination Treatment for Osimertinib Resistance Caused by KRAS G12C Mutation: A Report of Two Cases.
Ernst SM, Uzun S, Paats MS, van Marion R, Atmodimedjo PN, de Jonge E, van Schaik RHN, Aerts JGJV, von der Thüsen JH, Dubbink HJ, Dingemans AC. Ernst SM, et al. Among authors: von der thusen jh. JCO Precis Oncol. 2023 Sep;7:e2300451. doi: 10.1200/PO.23.00451. JCO Precis Oncol. 2023. PMID: 38096473 Free PMC article.
Hepatotoxicity in patients with non-small cell lung cancer treated with sotorasib after prior immunotherapy: a comprehensive clinical and pharmacokinetic analysis.
Ernst SM, Hofman MM, van der Horst TE, Paats MS, Heijboer FWJ, Aerts JGJV, Dumoulin DW, Cornelissen R, von der Thüsen JH, de Bruijn P, Hoop EO, Mathijssen RHJ, Koolen SLW, Dingemans AC. Ernst SM, et al. Among authors: von der thusen jh. EBioMedicine. 2024 Apr;102:105074. doi: 10.1016/j.ebiom.2024.105074. Epub 2024 Mar 19. EBioMedicine. 2024. PMID: 38507877 Free PMC article.
Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRASG12C-Mutated NSCLC Treated With Sotorasib.
Ernst SM, van Marion R, Atmodimedjo PN, de Jonge E, Mathijssen RHJ, Paats MS, de Bruijn P, Koolen SL, von der Thüsen JH, Aerts JGJV, van Schaik RHN, Dubbink HJ, Dingemans AC. Ernst SM, et al. Among authors: von der thusen jh. J Thorac Oncol. 2024 Jul;19(7):995-1006. doi: 10.1016/j.jtho.2024.04.007. Epub 2024 Apr 12. J Thorac Oncol. 2024. PMID: 38615940 Free article.
155 results